Your browser doesn't support javascript.
loading
Low-dose mesenchymal stem cell therapy for discogenic pain: safety and efficacy results from a 1-year feasibility study.
Bates, Dan; Vivian, David; Freitag, Julien; Wickham, James; Mitchell, Bruce; Verrills, Paul; Shah, Kiran; Boyd, Richard; Federman, Dean; Barnard, Adele; O'Connor, Lera; Young, Jacqui F.
Affiliation
  • Bates D; Melbourne Stem Cell Centre, Box Hill, Victoria, 3128, Australia.
  • Vivian D; Magellan Stem Cells, Victoria, Australia.
  • Freitag J; Metro Pain Group, Clayton, Victoria, 3168, Australia.
  • Wickham J; Monash Clinical Research, Clayton, Victoria, 3168, Australia.
  • Mitchell B; Melbourne Stem Cell Centre, Box Hill, Victoria, 3128, Australia.
  • Verrills P; Magellan Stem Cells, Victoria, Australia.
  • Shah K; Metro Pain Group, Clayton, Victoria, 3168, Australia.
  • Boyd R; Monash Clinical Research, Clayton, Victoria, 3168, Australia.
  • Federman D; Melbourne Stem Cell Centre, Box Hill, Victoria, 3128, Australia.
  • Barnard A; Magellan Stem Cells, Victoria, Australia.
  • O'Connor L; School of Dentistry & Medical Sciences, Charles Sturt University, Wagga Wagga, NSW, 2650, Australia.
  • Young JF; School of Dentistry & Medical Sciences, Charles Sturt University, Wagga Wagga, NSW, 2650, Australia.
Future Sci OA ; 8(5): FSO794, 2022 Mar.
Article in En | MEDLINE | ID: mdl-35662742
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Future Sci OA Year: 2022 Document type: Article Affiliation country: Australia
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Future Sci OA Year: 2022 Document type: Article Affiliation country: Australia